FMP

FMP

Enter

KIDS - OrthoPediatrics Corp...

photo-url-https://images.financialmodelingprep.com/symbol/KIDS.png

OrthoPediatrics Corp.

KIDS

NASDAQ

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

27.09 USD

-0.15 (-0.554%)

Latest KIDS News

Seeking Alpha

Aug 6, 2024

OrthoPediatrics Corp. (KIDS) Q2 2024 Earnings Call Transcript

OrthoPediatrics Corp. (NASDAQ:KIDS ) Q2 2024 Earnings Conference Call August 6, 2024 8:00 AM ET Company Participants Trip Taylor - Gilmartin Group David Bailey - President & Chief Executive Officer Fred Hite - Chief Financial Officer & Chief Operating Officer Conference Call Participants Rick Wise - Stifel Ryan Zimmerman - BTIG Matthew O'Brien - Piper Sandler Mike Matson - Needham Dave Turkaly - Citizens JMP Ravi Misra - Truist Operator Good morning, and thank you for standing-by. Welcome to the...

Read More

Zacks Investment Research

Aug 5, 2024

OrthoPediatrics (KIDS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for OrthoPediatrics (KIDS) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Read More

Zacks Investment Research

Aug 5, 2024

OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates

OrthoPediatrics (KIDS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.19 per share a year ago.

Read More

Zacks Investment Research

Jul 17, 2024

OrthoPediatrics (KIDS) Soars 7.5%: Is Further Upside Left in the Stock?

OrthoPediatrics (KIDS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Read More

Zacks Investment Research

May 6, 2024

OrthoPediatrics (KIDS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Read More

Zacks Investment Research

May 6, 2024

OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates

OrthoPediatrics (KIDS) came out with a quarterly loss of $0.30 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to loss of $0.29 per share a year ago.

Read More

GlobeNewsWire

Apr 22, 2024

OrthoPediatrics Corp. to Report First Quarter 2024 Financial Results on May 7, 2024

WARSAW, Ind., April 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2024 financial results on Monday, May 6, 2024, after the market closes. OrthoPediatrics will host a conference call on Tuesday, May 7, 2024, at 8:00 a.m. ET to discuss the results.

Read More

Zacks Investment Research

Mar 6, 2024

OrthoPediatrics (KIDS) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Read More

Zacks Investment Research

Mar 6, 2024

OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates

OrthoPediatrics (KIDS) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.32 per share a year ago.

Read More

GlobeNewsWire

Feb 22, 2024

OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024

WARSAW, Ind., Feb. 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2023 financial results on Wednesday, March 6, 2024, after the market closes. OrthoPediatrics will host a conference call on Thursday, March 7, 2024, at 8:00 a.m. ET to discuss the results.

Read More
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep